Hiberix
Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) · KIT · GlaxoSmithKline Biologicals SA
Hiberix is a kit containing haemophilus b conjugate vaccine (tetanus toxoid conjugate). Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- Hiberix
- Generic Name
- Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
- NDC Code (Product)
58160-818- Manufacturer
- GlaxoSmithKline Biologicals SA
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125347
- Marketing Start
- 12/21/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is Hiberix used for?
Hiberix contains Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate). It is a kit taken as directed. Consult your doctor for specific uses.
Is Hiberix a controlled substance?
Hiberix is not classified as a controlled substance by the DEA.
What is the generic name for Hiberix?
The generic name for Hiberix is Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate). There are no other listed brand versions of Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate).
What is the NDC code for Hiberix ?
The NDC (National Drug Code) for Hiberix is 58160-818, listed by GlaxoSmithKline Biologicals SA.
Other Hiberix Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)